Buy Oncobiologics Stock | ONS Stock Price & Latest News | Public
ONS

Oncobiologics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About ONS

    Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$101,75M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$1.74
    1 Year Low$0.50
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app